MMLTF yields 200.00% · JNJ yields 2.13%● Live data
📍 MMLTF pulled ahead of the other in Year 1
Combined, MMLTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MMLTF + JNJ for your $10,000?
MMG Limited, an investment holding company, engages in the exploration, development, and mining of copper, zinc, gold, silver, molybdenum, cobalt, and lead deposits in Australia and internationally. It operates through Las Bambas, Kinsevere, Dugald River, Rosebery, and Other segments. The company holds a 62.5% interest in the Las Bambas open-pit copper and molybdenum mine located in Cotabambas, Apurimac region of Peru; and 100% interest in the Kinsevere open-pit copper mine in the Haut-Katanga province of the Democratic Republic of the Congo. It also holds a 100% interest in the Dugald River underground zinc mine located near Cloncurry in North West Queensland; and the Rosebery underground polymetallic base metal mine located on Tasmania's west coast. The company was formerly known as Minmetals Resources Limited and changed its name to MMG Limited in September 2012. MMG Limited was incorporated in 1988 and is headquartered in Southbank, Australia. MMG Limited is a subsidiary of China Minmetals Corporation.
Full MMLTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.